Beta Bionics Inc(BBNX) - 2025 Q2 - Quarterly Results

EXHIBIT 99.1 Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance IRVINE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter ended June 30, 2025 and raised its full year guidance for the year ending December 31, 2025. Second Quarter 2025 Financial Results & Key Metrics See "Non-GAAP Financial Measures" below ...